Zoledronate and osteolysis Patient Reports February 12, 2012

Zoledronate Side Effects Report #4960505-1
Zoledronate side effect was reported by a Health Professional from GERMANY on Mar 20, 2006. Male patient, 63 years of age, was diagnosed with prostate cancer metastatic and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: calcinosis, osteolysis, osteonecrosis . Zoledronate dosage: unknown. Patient recovered.

Zoledronate Side Effects Report #4980228-2
Zoledronate side effect was reported by a Health Professional from GERMANY on Mar 20, 2006. Male patient, 63 years of age, was diagnosed with prostate cancer metastatic and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: calcinosis, osteolysis, osteonecrosis . Zoledronate dosage: unknown. Patient recovered.

Zoledronate Side Effects Report #4960484-7
Zoledronate side effect was reported by a Health Professional from GERMANY on Mar 20, 2006. Female patient, 72 years of age, was diagnosed with plasmacytoma and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone disorder, fistula , osteolysis, osteonecrosis , pain in jaw, purulent discharge, tooth extraction. Zoledronate dosage: unknown. Patient recovered.

Zoledronate Side Effects Report #4980249-X
Zoledronate side effect was reported by a Health Professional from GERMANY on Mar 20, 2006. Female patient, 72 years of age, was diagnosed with plasmacytoma and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone disorder, fistula , osteolysis, osteonecrosis , pain in jaw, purulent discharge, tooth extraction. Zoledronate dosage: unknown. Patient recovered.


Zoledronate Side Effects Report #5352012-1
Zoledronate side effect was reported by a Physician from BELGIUM on May 31, 2007. Male patient, 82 years of age, weighting 136.7 lb, was diagnosed with metastases to bone, multiple myeloma  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: osteolysis, osteonecrosis , pain in jaw. Zoledronate dosage: 4MG EVERY 4 WEEKS. During the same period patient was treated with CALCIUM CHLORIDE, VITAMIN D, THALIDOMIDE. Patient recovered.

Zoledronate Side Effects Report #4853457-6
Zoledronate side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2005. Female patient, 59 years of age, was diagnosed with metastases to bone, breast cancer  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: gingival erosion, osteolysis. Zoledronate dosage: 4 MG EVEY 6 MONTHS. During the same period patient was treated with FEMARA. Patient recovered.

Zoledronate Side Effects Report #6011265-7
Zoledronate side effect was reported by a Physician from ITALY on Dec 09, 2008. Female patient, weighting 158.7 lb, was diagnosed with metastases to bone, breast cancer  and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: debridement, dental operation, osteolysis, osteomyelitis, osteonecrosis . Zoledronate dosage: 4 MG, UNK. During the same period patient was treated with FEMARA, CALCIUM, VITAMIN D. Patient recovered.

Zoledronate Side Effects Report #5084345-0
Zoledronate side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, 58 years of age, was diagnosed with breast cancer metastatic and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, dental discomfort, oral discharge, osteolysis, osteonecrosis , sinusitis . Zoledronate dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI, DOCETAXEL, ADRIAMYCIN PFS, CYTOXAN, PACLITAXEL, ARIMIDEX, FEMARA. Patient recovered.

Zoledronate Side Effects Report #5113871-0
Zoledronate side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2006. Female patient, 58 years of age, was diagnosed with breast cancer metastatic and was treated with Zoledronate. After drug was administered, patient experienced the following side effects: bone debridement, dental discomfort, oral discharge, osteolysis, osteonecrosis , sinusitis . Zoledronate dosage: 4 MG, QMO. During the same period patient was treated with PAMIDRONATE DI, DOCETAXEL, ADRIAMYCIN PFS, CYTOXAN, PACLITAXEL, ARIMIDEX, FEMARA. Patient recovered.